Halcinonide

DB06786ApprovedWithdrawnSmall moleculeCorticosteroids

Halcinonide is a corticosteroid used for the management and symptomatic relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Halcinonide is marketed under the brand name Halog® by Ranbaxy Laboratories Inc.

Chemical structure of Halcinonide
Mechanism
Curator reviewed
Primary indication
Indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.Curator reviewed · 3 structured indications
Formula / weight
C24H32ClFO5 · 454.96 g/mol (avg)
First approval
Canada, 2005 · United States, 2008
Code names
SQ-18566
Brand names
  • Halog

Resolves to

Clinical / RWD
Structure
InChIKeyMUQNGPZZQDCDFT-JNQJZLCISA-NSMILES[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C

What you can answer from here — as of September 23, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
161Drug interactionsStructured to mechanism, not free text
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
21Marketed productsAcross 3 countries and 11 labellers
Sign in
1ATC codeIncluding every combination product, plus 16 drug categories
Sign in
11+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Halcinonide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account